Moderna Inc. (MRNA): Price and Financial Metrics
MRNA Price/Volume Stats
| Current price | $24.86 | 52-week high | $170.47 |
| Prev. close | $23.65 | 52-week low | $23.15 |
| Day low | $23.67 | Volume | 14,874,000 |
| Day high | $25.44 | Avg. volume | 11,098,965 |
| 50-day MA | $28.46 | Dividend yield | N/A |
| 200-day MA | $47.00 | Market Cap | 9.61B |
MRNA Stock Price Chart Interactive Chart >
Moderna Inc. (MRNA) Company Bio
Moderna, Inc. (/məˈdɜːrnə/ mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to produce an immune response. (Source:Wikipedia)
MRNA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | -33.33% |
| 1-year | -81.29% |
| 3-year | -82.66% |
| 5-year | -65.31% |
| YTD | -40.21% |
| 2024 | -58.19% |
| 2023 | -44.63% |
| 2022 | -29.28% |
| 2021 | 143.11% |
| 2020 | 434.10% |
Loading social stream, please wait...